Alfresa Holdings Corp. announced that it purchased Miyazaki Onsendo Shoten for an undisclosed price.
Alfresa has acquired all outstanding common shares of Miyazaki Onsendo Shoten to make it its wholly owned subsidiary. Houlihan Lokey, Inc. acted as an advisor to Alfresa Holdings.
Alfresa Holdings Corp. is a Japan-based holding company primarily engaged in the wholesale of drugs. Alfresa is one of the largest pharmaceutical wholesalers in Japan, with sales of approximately ¥2,586 billion ($23 billion USD) and EBITDA of approximately ¥42 billion ($373 million USD) as of FYE March 2022.
Miyazaki Onsendo Shoten was established in 1927 and is headquartered in Nagasaki, Japan. It is a wholesaler of pharmaceuticals, medical equipment and nursing and healthcare products.
According to data captured in the LevinPro HC database, this acquisition represents the 13th Pharmaceuticals transaction of 2023. Throughout all of 2022, 96 Pharmaceuticals acquisitions were announced.
